Jump to main content
Jump to site search

Issue 39, 2008
Previous Article Next Article

Functionalised cyclopentadienyl zirconium compounds as potential anticancer drugs

Author affiliations

Abstract

New neutral and ionic functionalised zirconocene dichloride compounds have been isolated and characterised. The ionic zirconocene exhibits excellent cytotoxicity against a range of human tumour cell lines, which represents the first active anticancer zirconocene dichloride compound.

Graphical abstract: Functionalised cyclopentadienyl zirconium compounds as potential anticancer drugs

Back to tab navigation

Publication details

The article was received on 17 Jul 2008, accepted on 07 Aug 2008 and first published on 18 Aug 2008


Article type: Communication
DOI: 10.1039/B812244J
Citation: Dalton Trans., 2008,0, 5293-5295
  •   Request permissions

    Functionalised cyclopentadienyl zirconium compounds as potential anticancer drugs

    O. R. Allen, R. J. Knox and P. C. McGowan, Dalton Trans., 2008, 0, 5293
    DOI: 10.1039/B812244J

Search articles by author

Spotlight

Advertisements